Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1989 1
1990 1
1992 2
1993 3
1994 2
1995 1
1996 2
1997 3
1998 3
1999 1
2003 1
2004 3
2005 1
2006 2
2007 6
2008 7
2009 9
2010 9
2011 8
2012 16
2013 8
2014 12
2015 15
2016 17
2017 14
2018 22
2019 24
2020 35
2021 34
2022 48
2023 49
2024 57
2025 71

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

451 results

Results by year

Filters applied: . Clear all
Page 1
A New Clinical Sign In Meningitis-Jamil's Sign.
Jamil S, Raza SS, Khan S, Jamil M. Jamil S, et al. J Ayub Med Coll Abbottabad. 2022 Jan-Mar;34(1):108-111. doi: 10.55519/JAMC-01-8696. J Ayub Med Coll Abbottabad. 2022. PMID: 35466637 Free article.
Survival with Cemiplimab in Recurrent Cervical Cancer.
Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9. Tewari KS, et al. Among authors: jamil s. N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187. N Engl J Med. 2022. PMID: 35139273 Clinical Trial.
Measles.
Keller JM, Dela Cruz CS, Pasnick S, Gross JE, Carlos WG, Maves R, Jamil S. Keller JM, et al. Among authors: jamil s. Am J Respir Crit Care Med. 2019 Jul 1;200(1):P1-P2. doi: 10.1164/rccm.2001P1. Am J Respir Crit Care Med. 2019. PMID: 31259630 Free article. No abstract available.
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell BCV, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 Jun 15;403(10444):2597-2605. doi: 10.1016/S0140-6736(24)00921-8. Epub 2024 May 17. Lancet. 2024. PMID: 38768626 Clinical Trial.
Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.
Oaknin A, Monk BJ, de Melo AC, Kim HS, Kim YM, Lisyanskaya AS, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin E, Takahashi S, Ramone D, Maćkowiak-Matejczyk B, Polastro L, Alia EMG, Colombo N, Makarova Y, Goh JC, Hasegawa K, Mora P, Pikiel J, Srivastav R, Rischin D, Rubio MJ, Perez J, Yoo SY, Gao B, Jamil S, Seebach F, Lowy I, Mathias M, Fury MG, Tewari KS. Oaknin A, et al. Among authors: jamil s. Eur J Cancer. 2025 Feb 5;216:115146. doi: 10.1016/j.ejca.2024.115146. Epub 2025 Jan 10. Eur J Cancer. 2025. PMID: 39798514 Clinical Trial.
Global multi-societies endorsement of the MAFLD definition.
Alboraie M, Tanwandee T, Xu X, Nikolova D, Estupiñan EC, Ghazinyan H, Alawadhi S, Ocama P, Aghayeva G, Piscoya A, Farahat T, Prasad P, Lesmana CRA, Joshi SR, Al-Busafi S, Milivojevic V, Kayamba V, Lee YY, Alam S, Tang C, Xie WF, Derbala M, Nan Y, Ndububa D, Zheng H, Zhao J, Alkhalidi N, Ghanem Y, Charatcharoenwitthaya P, Mahtab M, Hegazy NN, Sinkala E, Dovia CK, Mahamat MA, El-Shabrawi M, Hang DV, Vinker S, Hotayt B, Tahiri M, Bogomolov P, Afredj N, Shaltout I, Elwakil R, Hamed AE, Kamani L, Abdulla M, Assi C, Baatarkhuu O, Tarrah MA, Ajlouni Y, Abidine B, Muñoz C, Ali M, Salama E, Elamin A, Memon IA, Mirijanyan A, Jamil S, Nersesov AV, Ekanem N, Hamoudi W, Bright B, Casanovas T, Itodo E, Torres EA, Karin M, Zerem E, Turcan S, Dulskas A, Lupasco I, Jucov A, Tzeuton C, Sombie R, Lapshyna K, Dorofeyev A, Awuku YA, Duda HÜ, Ande R, Koofy NE, Kamal N, Pan Z, Peltec A, Qiao L, Rakotozafindrabe ALR, Salama A, Soliman R, Wafaa B, Debu M, Micah EA, Shiha G, Eslam M, Fouad Y. Alboraie M, et al. Among authors: jamil s. Ann Hepatol. 2024 Nov-Dec;29(6):101573. doi: 10.1016/j.aohep.2024.101573. Ann Hepatol. 2024. PMID: 39477629 Free article. No abstract available.
451 results